| Circulating immunoglobulins and transient lymphocytopenia in a sub-study of CAPRISA 012B, testing HIV monoclonal antibodies in a phase 1 trial P Sobia, S Mahomed, A Sivro, S Paul, F Osman, I Harkoo, N Garrett, ... Scientific Reports 14 (1), 13499, 2024 | | 2024 |
| Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023 JV Lazarus, TM White, K Wyka, SC Ratzan, K Rabin, HJ Larson, ... Nature Medicine, 1-5, 2024 | 3 | 2024 |
| Effectiveness of ChAdOx1 nCoV-19 and BBIBP-CorV vaccines against COVID-19-associated hospitalisation and death in the Seychelles infected adult population SN Theresa Pool, EH Shroff, A Chetty, L Lewis, YZ Nonhlanhla, ... Plos one 19 (4), e0299747, 2024 | | 2024 |
| Generation of allogeneic CAR-T circumvents functional deficits in patient-derived autologous product for glioblastoma MV Shaikh, SK Salim, J Wei, WT Maich, AA Anand, OY Tang, ... Cancer Research 84 (6_Supplement), 5241-5241, 2024 | | 2024 |
| uPAR as a novel immunotherapeutic target in recurrent glioblastoma WT Maich, MV Shaikh, A Puri, A Anand, C Chokshi, S Salim, N Savage, ... Cancer Research 84 (6_Supplement), 5238-5238, 2024 | | 2024 |
| Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation F Karim, C Riou, M Bernstein, Z Jule, G Lustig, S van Graan, RS Keeton, ... Nature Communications 15 (1), 2360, 2024 | 3 | 2024 |
| Incidence of Herpes Simplex Virus type 2 infection among women living with Human Immunodeficiency Virus in South Africa K Asare, N Garrett, M Khanyile, A Mindel, N Naicker, S Ngcapu, F Osman, ... SEXUALLY TRANSMITTED DISEASES 51 (1), S195-S196, 2024 | | 2024 |
| SARS-CoV-2 infection in immunosuppression evolves sub-lineages which independently accumulate neutralization escape mutations G Lustig, Y Ganga, HE Rodel, H Tegally, A Khairallah, L Jackson, S Cele, ... Virus Evolution 10 (1), vead075, 2024 | 3 | 2024 |
| Incidence of herpes simplex virus type 2 positivity among women living with human immunodeficiency virus in South Africa K Asare, S Ngcapu, F Osman, A Mindel, N Naicker, M Khanyile, ... International journal of STD & AIDS 35 (1), 58-66, 2024 | | 2024 |
| Metformin increases cell viability and regulates pro-inflammatory response to Mtb N Naicker, H Rodel, R Perumal, Y Ganga, M Bernstein, N Benede, ... Infection and Drug Resistance, 3629-3638, 2023 | 3 | 2023 |
| Evolution and neutralization escape of the SARS-CoV-2 BA. 2.86 subvariant K Khan, G Lustig, C Römer, K Reedoy, Z Jule, F Karim, Y Ganga, ... Nature Communications 14 (1), 8078, 2023 | 43 | 2023 |
| Host genetic variation at a locus near CHD1L impacts HIV sequence diversity in a South African population VE Schulz, JF Tuff, RH Tough, L Lewis, B Chimukangara, N Garrett, ... Journal of Virology 97 (10), e00954-23, 2023 | 1 | 2023 |
| Infectious diseases and the Sustainable Development Goals: progress, challenges and future directions Q Abdool Karim, SS Abdool Karim Nature Reviews Microbiology 21 (10), 626-627, 2023 | 2 | 2023 |
| Current Issue Introduction RF Corner American Journal of Physical Medicine & Rehabilitation 102 (10), e133-e136, 2023 | | 2023 |
| Threatening the global AIDS response—obstacles to PEPFAR’s reauthorization SS Abdool Karim, F Barre-Sinoussi, HE Varmus, D Serwadda, E Bukusi, ... New England Journal of Medicine 389 (13), 1159-1161, 2023 | 4 | 2023 |
| Threatening the Future of Global Health-NIH Policy Changes on International Research Collaborations. AI Ko, SSA Karim, C Morel, S Swaminathan, P Daszak, GT Keusch The New England Journal of Medicine, 2023 | 1 | 2023 |
| SYST-33 GENERATION OF ALLOGENEIC CAR-T CIRCUMVENTS FUNCTIONAL DEFICITS IN PATIENT-DERIVED AUTOLOGOUS PRODUCT FOR GLIOBLASTOMA MV Shaikh, SK Salim, WT Maich, A Anand, J Wei, MK Subapanditha, ... Neuro-Oncology Advances 5 (Suppl 3), iii34, 2023 | | 2023 |
| AUTOLOGOUS PATIENT-DERIVED CAR-TS SHOW FUNCTIONAL DEFICITS AGAINST HUMAN GLIOBLASTOMA SK Salim, V Shaikh, WT Maich, A Anand, B Brakel, J Wei, ... Neuro-Oncology Advances 5 (Suppl 2), i6, 2023 | | 2023 |
| GENETIC SCREENING REVEALS DEPENDENCY ON FEN1 TO RESIST TEMOZOLOMIDE IN TREATMENT-RESISTANT GLIOBLASTOMA STEM CELLS B Brakel, A Saleh, M Saleh, P Miletic, S Salim, W Maich, KR Brown, ... Neuro-Oncology Advances 5 (Suppl 2), i1, 2023 | | 2023 |
| Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection SK Ahuja, MS Manoharan, GC Lee, LR McKinnon, JA Meunier, M Steri, ... Nature communications 14 (1), 3286, 2023 | 30 | 2023 |
Lynn MorrisNational Institute for Communicable Diseases在 nicd.ac.za 的电子邮件经过验证
